bearish•Zhejiang Orient Gene Biotech C•03 Dec 2023 09:29
China Healthcare Weekly (Dec.1) - Medical Device VBP, Biotech to Breakeven Soon, Orient Gene Biotech
VBP result for intraocular lens/sports medicine consumables is better than expected.There’s a chance to see Chinese Biotech turn loss into profits...
•10 Feb 2023 08:55
Shanghai Haohai Biological Technology (688366.CH/6826.HK)- Disappointing Earnings and Gloomy Outlook
Continuous M&A fails to bring ideal performance to Haohai. Medical aesthetics is the main growth driver, but Haohai is lack of competitiveness....
bearish•Quantitative Analysis•19 Nov 2023 10:10
Hong Kong Connect Flows (Nov 17th): Meituan, Tencent, Xiaomi
We analyzed southbound Hong Kong connect flows in the past week and highlight Hongkong connect flows for Meituan, Tencent and Xiaomi.
bearish•Quantitative Analysis•05 Nov 2023 10:10